<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2021.259</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-1149</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Features and relationships of metabolic syndrome components in men with androgen deficiency. Part 2. Disorders of carbohydrate and purine metabolism. Retrospective study data</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности и взаимосвязи компонентов метаболического синдрома у мужчин с андрогенным дефицитом. Часть 2. Нарушения углеводного и пуринового обмена. Данные ретроспективного исследования</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7954-0437</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлова</surname><given-names>З. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlova</surname><given-names>Z. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павлова Зухра Шариповна – к.м.н., врач-эндокринолог, старший научный сотрудник отдела возраст-ассоциированных заболеваний, медицинский научно-образовательный центр </p><p>119234 Москва, Ленинские горы, д. 1, стр. 12</p></bio><bio xml:lang="en"><p>Zukhra Sh. Pavlova – MD, PhD, Endocrinologist, Senior Researcher, Department of AgeAssociated Diseases, Medical Research and Education Center </p><p>1 bldg. 12, Leninskie Gory, Moscow 119234</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5939-0344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гревина</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Grevina</surname><given-names>V. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гревина Валерия Юрьевна – студент 6-го курса факультета фундаментальной медицины </p><p>119234 Москва, Ленинские горы, д. 1, стр. 12</p></bio><bio xml:lang="en"><p>Valeria Yu. Grevina – 6th year Student, Faculty of Fundamental Medicine</p><p>1 bldg. 12, Leninskie Gory, Moscow 119234</p></bio><email xlink:type="simple">grevinav@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2021</year></pub-date><volume>15</volume><issue>6</issue><fpage>705</fpage><lpage>714</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Pavlova Z.S., Grevina V.Y., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Павлова З.Ш., Гревина В.Ю.</copyright-holder><copyright-holder xml:lang="en">Pavlova Z.S., Grevina V.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/1149">https://www.gynecology.su/jour/article/view/1149</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Currently, few epidemiological data on a relation between impaired purine and carbohydrate metabolism and testosterone deficiency in overweight men due to adipose tissue and metabolic syndrome (MS) are available.</p></sec><sec><title>Aim</title><p>Aim: to study relationships between disturbances in carbohydrate and purine metabolism and testosterone level in men with adipose tissue excess and MS.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. There were enrolled 64 overweight men to the study. The patients were divided into 3 groups based on the body mass index (BMI): group 1 – with overweight (n = 24), group 2 – with the first degree of obesity (n = 21), group 3 – with the second and third degree of obesity (n = 19). A correlation analysis was carried out between the data on carbohydrate and purine metabolism related to testosterone level and body composition, as well as additionally assessing the level of inter-group difference.</p></sec><sec><title>Results</title><p>Results. A relationship between the parameters of carbohydrate and purine metabolism and the level of total testosterone has been established along with overdeveloped adipose tissue. A weak negative correlation was found across the sample between testosterone and glucose, insulin, and the НОМА-IR (Homeostasis Model Assessment of Insulin Resistance) index. i.e., the higher the glucose level, the higher НОМА-IR index, and the lower the testosterone level. In addition, it was found that along with increasing BMI it was paralleled with higher insulin level. The number of patients with fasting blood glucose levels above 5.6 mmol/L and insulin resistance also increased. In the group with I degree of obesity, a negative correlation was found between the levels of total testosterone and uric acid.</p></sec><sec><title>Conclusion</title><p>Conclusion. Thus, the thesis is confirmed that the more significant the violation of carbohydrate and purine metabolism, the more profound could be androgenic deficiency. Thus, it is obvious that normalization of body composition and removal of excessive adipose tissue would provide a more effective solution in choosing a strategy to treat androgen deficiency and disorders of carbohydrate and purine metabolism in overweight men.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. На сегодняшний день очень мало эпидемиологических данных относительно взаимосвязи нарушений пуринового и углеводного обмена с дефицитом тестостерона у мужчин с избыточной массой тела за счет жировой ткани и метаболическим синдромом (МС).</p></sec><sec><title>Цель исследования</title><p>Цель исследования: изучение взаимосвязей между нарушениями углеводного и пуринового обмена и уровнем тестостерона у мужчин с избытком жировой ткани и МС.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование были включены 64 пациента мужского пола с избыточной массой тела. Пациентов разделили на 3 группы в зависимости от индекса массы тела (ИМТ): группа 1 с избыточной массой тела (n = 24), группа 2 с ожирением I степени (n = 21), группа 3 с ожирением II и III степени (n = 19). Анализировали показатели углеводного и пуринового обмена во взаимосвязи с андрогенным статусом и параметрами состава тела, а также определяли уровень различий между группами.</p></sec><sec><title>Результаты</title><p>Результаты. Выявлена взаимосвязь между параметрами углеводного и пуринового обмена и уровнем общего тестостерона, сформированная на фоне избыточно развитой жировой ткани. По всей выборке была определена слабая отрицательная корреляция между значениями тестостерона и глюкозы, инсулина, индексом инсулинорезистентности НОМА-IR (англ. Homeostasis Model Assessment of Insulin Resistance), т. е. чем выше содержание глюкозы и, соответственно инсулина, тем выше индекс НОМА-IR и тем ниже уровень тестостерона. Установлено, что с ростом ИМТ росло количество пациентов с концентрацией глюкозы крови натощак свыше 5,6 ммоль/л и инсулинорезистентностью, отмечен рост уровня инсулина в зависимости от ИМТ. В группе с ожирением I степени заметная и тоже отрицательная корреляция выявлена между значениями общего тестостерона и мочевой кислоты.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные взаимосвязи подтверждают, что чем значительнее нарушения углеводного и пуринового обмена, тем существеннее андрогенный дефицит. Таким образом, очевидно, что наиболее эффективным решением в выборе стратегии лечения андрогенного дефицита и нарушений углеводного и пуринового обмена у мужчин с избыточной массой тела является нормализация состава тела и избавление от избытка жировой ткани.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>глюкоза</kwd><kwd>инсулин</kwd><kwd>индекс инсулинорезистентности</kwd><kwd>НОМА-IR</kwd><kwd>мочевая кислота</kwd><kwd>тестостерон</kwd><kwd>ожирение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glucose</kwd><kwd>insulin</kwd><kwd>insulin resistance</kwd><kwd>НОМА-IR index</kwd><kwd>uric acid</kwd><kwd>testosterone</kwd><kwd>obesity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Guh D.P., Zhang W., Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. https://doi.org/10.1186/1471-2458-9-88.</mixed-citation><mixed-citation xml:lang="en">Guh D.P., Zhang W., Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. https://doi.org/10.1186/1471-2458-9-88.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gong M., Wen S., Nguyen T. et al. Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:943–62. https://doi.org/10.2147/DMSO.S232377.</mixed-citation><mixed-citation xml:lang="en">Gong M., Wen S., Nguyen T. et al. Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:943–62. https://doi.org/10.2147/DMSO.S232377.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Saklayen M.G. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https://doi.org/10.1007/s11906-018-0812-z.</mixed-citation><mixed-citation xml:lang="en">Saklayen M.G. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https://doi.org/10.1007/s11906-018-0812-z.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wong Y., Cook P., Roderick P., Somani B.K. Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol. 2016;30(3):246–53. https://doi.org/10.1089/end.2015.0567.</mixed-citation><mixed-citation xml:lang="en">Wong Y., Cook P., Roderick P., Somani B.K. Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol. 2016;30(3):246–53. https://doi.org/10.1089/end.2015.0567.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц В.Я. Воспаление жировой ткани. Часть 1. Морфологические и функциональные проявления. Проблемы эндокринологии. 2009;55(4):44–9. https://doi.org/10.14341/probl200955444-49.</mixed-citation><mixed-citation xml:lang="en">Shvarts V.Ya. Adipose tissue inflammation. Part 1. Morphological and functional manifestations. [Vospalenie zhirovojtkani. Chast' 1. Morfologicheskie i funkcional'nye proyavleniya]. Problemy endokrinologii. 2009;55(4):44–9. (In Russ.). https://doi.org/10.14341/probl200955444-49.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц В.Я. Воспаление жировой ткани. Часть 2. Патогенетическая роль при сахарном диабете 2-го типа. Проблемы эндокринологии. 2009;55(5):43–8. https://doi.org/10.14341/probl200955543-48.</mixed-citation><mixed-citation xml:lang="en">Shvarts V.Ya. Inflammation of adipose tissue. Part 2. Pathogenetic role in type 2 diabetes mellitus. [Vospalenie zhirovoj tkani. Chast' 2. Patogeneticheskaya rol' pri saharnom diabete 2-go tipa]. Problemy endokrinologii. 2009;55(5):43–8. (In Russ.). https://doi.org/10.14341/probl200955543-48.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц В.Я. Воспаление жировой ткани. Часть 3. Патогенетическая роль в развитии атеросклероза. Проблемы эндокринологии. 2009;55(6):40–5. https://doi.org/10.14341/probl200955640-45.</mixed-citation><mixed-citation xml:lang="en">Shvarts V. Inflammation of adipose tissue. Part 3. Pathogenetic role in the development of atherosclerosis. [Vospalenie zhirovoj tkani. Chast' 3. Patogeneticheskaya rol' v razvitii ateroskleroza]. Problemy endokrinologii. 2009;55(6):40–5. (In Russ.). https://doi.org/10.14341/probl200955640-45.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Гамидов С.И., Шатылко Т.В., Гасанов Н.Г. Мужское здоровье и ожирение – диагностика и терапевтические подходы. Ожирение и метаболизм. 2019;16(3):29–36. https://doi.org/https://doi.org/10.14341/omet10314.</mixed-citation><mixed-citation xml:lang="en">Gamidov S.I., Shatylko T.V., Hasanov N.G. Male health and obesity – diagnostis and therapeutic approach. [Muzhskoe zdorov'e i ozhirenie – diagnostika i terapevticheskie podhody]. Ozhirenie i metabolizm. 2019;16(3):29–36. (In Russ.). https://doi.org/https://doi.org/10.14341/omet10314.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Carruthers M., Trinick T.R., Jankowska E., Traish A.M. Are the adverse effects of glitazones linked to induced testosterone deficiency? Cardiovasc Diabetol. 2008;7:30. https://doi.org/10.1186/1475-2840-7-30.</mixed-citation><mixed-citation xml:lang="en">Carruthers M., Trinick T.R., Jankowska E., Traish A.M. Are the adverse effects of glitazones linked to induced testosterone deficiency? Cardiovasc Diabetol. 2008;7:30. https://doi.org/10.1186/1475-2840-7-30.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова З.Ш., Голодников И.И. Ожирение = воспаление. Патогенез. Чем это грозит мужчинам? Медицинский вестник Юга России. 2020;11(4):6–23. https://doi.org/10.21886/2219-8075-2020-11-4-6-23.</mixed-citation><mixed-citation xml:lang="en">Pavlova Z.Sh., Golodnikov I.I. Obesity = inflammation. Pathogenesis. How does this threaten men? [Ozhirenie = vospalenie. Patogenez. Chem eto grozit muzhchinam?] Medicinskij vestnik Yuga Rossii. 2020;11(4):6–23. (In Russ.). https://doi.org/10.21886/2219-8075-2020-11-4-6-23.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ткачук В.А., Воротников А.А. Молекулярные механизмы развития резистентности к инсулину. Сахарный диабет. 2014;(2):29–40. https://doi.org/10.14341/DM2014229-40.</mixed-citation><mixed-citation xml:lang="en">Tkachuk V.A., Vorotnikov A.A. Molecular mechanisms of insulin resistance. [Molekulyarnye mekhanizmy razvitiya rezistentnosti k insulin]. Saharnyj diabet. 2014;(2):29–40. (In Russ.). https://doi.org/10.14341/DM2014229-40.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Мишина Е.Е., Майоров А.Ю., Богомолов П.О. и др. Неалкогольная жировая болезнь печени: причина или следствие инсулинорезистентности? Сахарный диабет. 2017;20(5):335–43. https://doi.org/10.14341/DM9372.</mixed-citation><mixed-citation xml:lang="en">Mishina E.E., Mayorov A.Yu., Bogomolov P.O. et al. Nonalcoholic fatty liver disease: a cause or a consequence of insulin resistance? [Nealkogol'naya zhirovaya bolezn' pecheni: prichina ili sledstvie insulinorezistentnosti?] Saharnyj diabet. (In Russ.). 2017;20(5):335–43. https://doi.org/10.14341/DM9372.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова З.Ш., Голодников И.И., Камалов А.А., Низов А.Н. Роль фруктозы в генезе нефролитиаза. Урология. 2019;(1):114–8. https://doi.org/10.18565/urology.2019.1.114-118.</mixed-citation><mixed-citation xml:lang="en">Pavlova Z.Sh., Golodnikov I.I., Kamalov A.A., Nizov A.N. A role of fructose in urinary stone formation. [Rol' fruktozy v geneze nefrolitiaza]. Urologiya. 2019;(1):114–8. (In Russ.). https://doi.org/10.18565/urology.2019.1.114-118.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X., Jiang X., Wang L. et al. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study. J Transl Med. 2019;17(1):341. https://doi.org/10.1186/s12967-019-2074-1.</mixed-citation><mixed-citation xml:lang="en">Huang X., Jiang X., Wang L. et al. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study. J Transl Med. 2019;17(1):341. https://doi.org/10.1186/s12967-019-2074-1.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Liu F., Du G.L., Song N. et al. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012). Lipids Health Dis. 2020;19(1):58. https://doi.org/10.1186/s12944-020-01211-z.</mixed-citation><mixed-citation xml:lang="en">Liu F., Du G.L., Song N. et al. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012). Lipids Health Dis. 2020;19(1):58. https://doi.org/10.1186/s12944-020-01211-z.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ni Q., Lu X., Chen C. et al. Risk factors for the development of hyperuricemia: a STROBEcompliant cross-sectional and longitudinal study. Medicine (Baltimore). 2019;98(42):e17597. https://doi.org/10.1097/MD.0000000000017597.</mixed-citation><mixed-citation xml:lang="en">Ni Q., Lu X., Chen C. et al. Risk factors for the development of hyperuricemia: a STROBEcompliant cross-sectional and longitudinal study. Medicine (Baltimore). 2019;98(42):e17597. https://doi.org/10.1097/MD.0000000000017597.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kuwabara M., Kuwabara R., Hisatome I. et al. "Metabolically healthy" obesity and hyperuricemia increase risk for hypertension and diabetes: 5-year Japanese cohort study. Obesity (Silver Spring). 2017;25(11):1997–2008. https://doi.org/10.1002/oby.22000.</mixed-citation><mixed-citation xml:lang="en">Kuwabara M., Kuwabara R., Hisatome I. et al. "Metabolically healthy" obesity and hyperuricemia increase risk for hypertension and diabetes: 5-year Japanese cohort study. Obesity (Silver Spring). 2017;25(11):1997–2008. https://doi.org/10.1002/oby.22000.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Qin T., Zhou X., Wang J. et al. Hyperuricemia and the prognosis of hypertensive patients: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2016;18(12):1268–78. https://doi.org/10.1111/jch.12855.</mixed-citation><mixed-citation xml:lang="en">Qin T., Zhou X., Wang J. et al. Hyperuricemia and the prognosis of hypertensive patients: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2016;18(12):1268–78. https://doi.org/10.1111/jch.12855.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J., Liu C., Fu L. et al. The association of serum uric acid with metabolic syndrome and its components – from a single-clinical centre in China. Int J Clin Pract. 2021;75(4):e13845. https://doi.org/10.1111/ijcp.13845.</mixed-citation><mixed-citation xml:lang="en">Xu J., Liu C., Fu L. et al. The association of serum uric acid with metabolic syndrome and its components – from a single-clinical centre in China. Int J Clin Pract. 2021;75(4):e13845. https://doi.org/10.1111/ijcp.13845.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kuwabara M., Niwa K., Hisatome I. et al. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study. Hypertension. 2017;69(6):1036–44. https://doi.org/10.1161/HYPERTENSIONAHA.116.08998.</mixed-citation><mixed-citation xml:lang="en">Kuwabara M., Niwa K., Hisatome I. et al. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study. Hypertension. 2017;69(6):1036–44. https://doi.org/10.1161/HYPERTENSIONAHA.116.08998.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Masuo K., Kawaguchi H., Mikami H. et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–80. https://doi.org/10.1161/01.HYP.0000091371.53502.D3.</mixed-citation><mixed-citation xml:lang="en">Masuo K., Kawaguchi H., Mikami H. et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–80. https://doi.org/10.1161/01.HYP.0000091371.53502.D3.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yoo T.W., Sung K.C., Shin H.S. et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–33. https://doi.org/10.1253/circj.69.928.</mixed-citation><mixed-citation xml:lang="en">Yoo T.W., Sung K.C., Shin H.S. et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–33. https://doi.org/10.1253/circj.69.928.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова З.Ш., Гревина В.Ю. Особенности и взаимосвязи компонентов метаболического синдрома у мужчин с андрогенным дефицитом. Часть 1. Взаимосвязаны ли параметры состава тела, уровень половых гормонов и АД между собой? Акушерство, Гинекология и Репродукция. 2021;15(5):534–47. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.256.</mixed-citation><mixed-citation xml:lang="en">Pavlova Z.Sh., Grevina V.Yu. Features and relationships of metabolic syndrome components in men with androgen deficiency. Part 1. Are body composition parameters, sex hormone levels and blood pressure interrelated? [Osobennosti i vzaimosvyazi komponentov metabolicheskogo sindroma u muzhchin s androgennym deficitom. Chast' 1. Vzaimosvyazany li parametry sostava tela, uroven' polovyh gormonov i AD mezhdu soboj?]. Obstetrics, Gynecology and Reproduction. 2021;15(5):534–47. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.256.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mongioì L.M., Cimino L., Condorelli R.A. et al. Effectiveness of a very low calorie ketogenic diet on testicular function in overweight/obese men. Nutrients. 2020;12(10):2967. https://doi.org/10.3390/nu12102967.</mixed-citation><mixed-citation xml:lang="en">Mongioì L.M., Cimino L., Condorelli R.A. et al. Effectiveness of a very low calorie ketogenic diet on testicular function in overweight/obese men. Nutrients. 2020;12(10):2967. https://doi.org/10.3390/nu12102967.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
